GN
Genetic Technologies Limited
GNTLF · OTC
$1.00 +0.00% (+$0.00)
Market Cap $1.87B
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 192.87x
P/B 1,019.21x
P/E N/A
Growth
78 /100
Growing Rev. growth 93.52%
Book val. growth 56.03%
EPS growth N/A
Profitability
16 /100
Weak Gross margin 40.37%
FCF margin 100.41%
Net margin 124.24%
Quality
21 /100
Poor ROIC 429.44%
Asset turnover 1.56x
ROA 194.25%
Debt
46 /100
Moderate Debt/Equity 0.48x
Int. coverage -231.79x
Current ratio 0.88x
Stability
15 /100
Unstable Beta 0.16x
Profitable years 0
Rev. volatility 339.49%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na GNTLF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Kevin Camilleri
Employees
55
Headquarters
Maroochydore